Home/ Supplements/ Niacin/ Niacin Lozenge 50 mg

Niacin Lozenge 50 mg

product on market Lozenge Seeking Health Safety: 60/100
60/100

Review before taking

  • Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Niacin is used to support lipid profiles and cellular energy metabolism, with strong evidence for its role in cholesterol management. However, the safety score indicates potential concerns, as high doses may cause flushing or liver enzyme elevations. This formulation provides a low-dose delivery method for these effects.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)

✨ AI-generated · Qwen 3.6 · grounded in 2 sources · methodology

This product received a lower safety score because it contains 50mg of Niacin, which exceeds the recommended Tolerable Upper Intake Level of 35mg.

Label

Product Label

Label for Niacin Lozenge 50 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Lozenge(s)
Serving Size
100
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

50 mg (313% DV)
Exceeds UL by 1.4× (UL: 35 mg) 196 studies (A:5, B:63)

Other Ingredients

Xylitol Ascorbyl Palmitate Malic Acid natural Cherry flavor Silica
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: Take 1 lozenge as directed by your healthcare professional. Lozenge may be broken into smaller pieces if lower dosage is desired.

Warnings & Precautions

Children and pregnant or lactating women should consult their healthcare professional prior to use.

Children and pregnant or lactating women should consult their healthcare professional prior to use.

Do not use if tamper seal is damaged.

Storage: Keep closed in a cool, dry place out of reach by children.

Formulation Notes

Does Not Contain: Milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, artificial colors, or artificial flavors.

Additional Information

Storage: Keep closed in a cool, dry place out of reach by children.

Physician formulated

Niacin Lozenge meets or exceeds cGMP quality standards.

REV. 011017 ZCL-SKGHEALTH-NIATAB-01

This package is completely recyclable

Metadata

Product Details

UPC / SKU7 98295 54905 1
DSLD Entry Date2018-02-23
Product TypeVitamin
FormLozenge
BrandSeeking Health
DSLD ID174550
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

Coenzymated B-3 25 mg
Source Naturals · Lozenge
100
View all Niacin products →
Niacin research Best Niacin All Niacin products More from Seeking Health View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.